Delivery Order SPE2DB20D2104-SPE2DB25FMSHB
- Not listed
- The Defense Logistics Agency awarded a $60,790.03 delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $3,186.89 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count packages). The contract is firm fixed price with no set-aside designation and was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,761.65. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $25,697.77 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,036.26 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 25 mg tablets (90-count units) under a firm fixed price contract. The award was made on May 1, 2025, with an ultimate completion date of May 2, 2025, and carries no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,002.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Myrbetriq ER 50 mg tablets, with completion scheduled for September 9, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery under AmerisourceBergen's existing contract vehicle with DLA, supporting federal medical procurement needs across military and veteran healthcare systems. The product will be delivered to the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $15,833.37. This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSHBDelivery Order
The Defense Logistics Agency awarded a $6,811.16 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 3, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical contract vehicle supports military and federal healthcare systems globally, enabling AmerisourceBergen to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The contract reflects AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical procurement, particularly serving Defense Health Agency and other government healthcare customers through flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 6/2/25 |